Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.
European heart journal
View this publicationEuropean heart journal
View this publicationThe Journal of dermatology
View this publicationAllergy
View this publicationThe New England journal of medicine
View this publicationJournal of leukocyte biology
View this publicationJournal of geriatric oncology
View this publicationRheumatology (Oxford, England)
View this publicationScience (New York, N.Y.)
View this publicationHaematologica
View this publicationMolecular aspects of medicine
View this publication